This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Supeudol 20

Starting date:
April 5, 2013
Posting date:
April 23, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-26855

Recalled Products

  1. Supeudol 20

Reason

The recall is initiated following an out-of-specification result for the assay of oxycodone hydrochloride obtained in stability (6 month time point).

Depth of distribution

Wholesalers and pharmacies in Canada.

Affected products

A. Supeudol 20

DIN, NPN, DIN-HIM
DIN 00392472
Dosage form
  • Suppository
Strength
  • 20 mg
Lot or serial number
  • 133429A
Companies
Recalling Firm
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA

Date modified: